Intracameral Injection of Bevacizumab for the Treatment of Neovascular Glaucoma
نویسندگان
چکیده
منابع مشابه
Intracameral injection of bevacizumab for the treatment of neovascular glaucoma.
PURPOSE To assess the duration of the effect of intracameral bevacizumab in patients presenting with rubeosis iridis and neovascular glaucoma (NVG). METHODS Retrospective analysis of 24 consecutive eyes of 24 patients with decompensated NVG (> 21 mm Hg) treated with a single intracameral injection of bevacizumab over a minimum follow-up of 6 months. The endpoint of the study was the need for ...
متن کامل[Intracameral bevacizumab (Avastin®) in the management of neovascular glaucoma surgery].
PURPOSE To describe a case series of neovascular glaucoma treated with intracameral bevacizumab prior to filtering surgery. DESIGN Descriptive, retrospective case series. METHODS Five eyes of 5 patients with neovascular glaucoma due to any cause candidates to filtering surgery who had previously received an injection of intracameral bevacizumab (1.25 mg/0.05 ml) as treatment for neovascular...
متن کاملIntravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
Neovascular glaucoma is a secondary glaucoma with grave prognosis which follows ischemic retinal disorders in the majority of cases. Mediators that induce new vessel formation such as the vascular endothelial growth factor-A seem to play a key role in the pathophysiology of this condition. Herein, we report 2 cases with neovascular glaucoma secondary to ischemic central retinal vein occlusion w...
متن کاملConcentration of Vascular Endothelial Growth Factor After Intracameral Bevacizumab Injection in Eyes With Neovascular Glaucoma
PURPOSE To study the concentration of vascular endothelial growth factor (VEGF) in the aqueous humor before and after intracameral injection of bevacizumab in eyes with neovascular glaucoma, and to detect the duration of an anti-VEGF effect of bevacizumab in the anterior chamber. METHODS In this prospective interventional case series, 1.25 mg of bevacizumab was injected into the anterior cham...
متن کاملEfficacy and Safety of Intracameral Bevacizumab for Treatment of Neovascular Glaucoma
PURPOSE To evaluate the long-term efficacy and safety of intracameral bevacizumab in patients with neovascular glaucoma. METHODS This retrospective study included 26 eyes of 26 neovascular glaucoma patients who received intracameral bevacizumab injection between January 2013 and May 2015, and were followed-up for at least 1 year. All patients were treated with topical and/or systemic intraocu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Ophthalmologica
سال: 2011
ISSN: 1423-0267,0030-3755
DOI: 10.1159/000327364